Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection

Conditions:   Hepatitis C;   Lichen Planus;   Vasculitis;   Autoimmune Diseases
Interventions:   Drug: Ribavirin;   Drug: Betamethasone
Sponsor:   Tanta University
Recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days